vs

Side-by-side financial comparison of Charles River Laboratories (CRL) and GRANITE CONSTRUCTION INC (GVA). Click either name above to swap in a different company.

GRANITE CONSTRUCTION INC is the larger business by last-quarter revenue ($1.2B vs $994.2M, roughly 1.2× Charles River Laboratories). GRANITE CONSTRUCTION INC runs the higher net margin — 4.5% vs -27.8%, a 32.3% gap on every dollar of revenue. On growth, GRANITE CONSTRUCTION INC posted the faster year-over-year revenue change (19.2% vs -0.8%). GRANITE CONSTRUCTION INC produced more free cash flow last quarter ($128.8M vs $58.6M). Over the past eight quarters, GRANITE CONSTRUCTION INC's revenue compounded faster (31.7% CAGR vs -0.9%).

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

Granite Construction Inc. is a civil construction company and aggregate producer, a member of the S&P 600 Index based and founded in Watsonville, California, and is the parent corporation of Granite Construction Company. The company is both a heavy civil construction contractor and construction aggregate manufacturer, owning or leasing quarries in several Western states for extracting mostly sands, gravel, and crushed stone products. The company was under investigation from the SEC from 2019 ...

CRL vs GVA — Head-to-Head

Bigger by revenue
GVA
GVA
1.2× larger
GVA
$1.2B
$994.2M
CRL
Growing faster (revenue YoY)
GVA
GVA
+20.1% gap
GVA
19.2%
-0.8%
CRL
Higher net margin
GVA
GVA
32.3% more per $
GVA
4.5%
-27.8%
CRL
More free cash flow
GVA
GVA
$70.2M more FCF
GVA
$128.8M
$58.6M
CRL
Faster 2-yr revenue CAGR
GVA
GVA
Annualised
GVA
31.7%
-0.9%
CRL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CRL
CRL
GVA
GVA
Revenue
$994.2M
$1.2B
Net Profit
$-276.6M
$52.0M
Gross Margin
14.4%
Operating Margin
-28.5%
6.4%
Net Margin
-27.8%
4.5%
Revenue YoY
-0.8%
19.2%
Net Profit YoY
-28.9%
25.4%
EPS (diluted)
$-5.57
$1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRL
CRL
GVA
GVA
Q4 25
$994.2M
$1.2B
Q3 25
$1.0B
$1.4B
Q2 25
$1.0B
$1.1B
Q1 25
$984.2M
$699.5M
Q4 24
$1.0B
$977.3M
Q3 24
$1.0B
$1.3B
Q2 24
$1.0B
$1.1B
Q1 24
$1.0B
$672.3M
Net Profit
CRL
CRL
GVA
GVA
Q4 25
$-276.6M
$52.0M
Q3 25
$54.4M
$102.9M
Q2 25
$52.3M
$71.7M
Q1 25
$25.5M
$-33.7M
Q4 24
$-214.5M
$41.5M
Q3 24
$69.7M
$79.0M
Q2 24
$94.1M
$36.9M
Q1 24
$73.0M
$-31.0M
Gross Margin
CRL
CRL
GVA
GVA
Q4 25
14.4%
Q3 25
18.2%
Q2 25
17.7%
Q1 25
12.0%
Q4 24
15.4%
Q3 24
34.6%
15.9%
Q2 24
34.5%
15.2%
Q1 24
34.1%
8.1%
Operating Margin
CRL
CRL
GVA
GVA
Q4 25
-28.5%
6.4%
Q3 25
13.3%
10.0%
Q2 25
9.7%
9.2%
Q1 25
7.6%
-5.7%
Q4 24
-16.7%
6.2%
Q3 24
11.6%
8.2%
Q2 24
14.8%
7.9%
Q1 24
12.5%
-6.4%
Net Margin
CRL
CRL
GVA
GVA
Q4 25
-27.8%
4.5%
Q3 25
5.4%
7.2%
Q2 25
5.1%
6.4%
Q1 25
2.6%
-4.8%
Q4 24
-21.4%
4.2%
Q3 24
6.9%
6.2%
Q2 24
9.2%
3.4%
Q1 24
7.2%
-4.6%
EPS (diluted)
CRL
CRL
GVA
GVA
Q4 25
$-5.57
$1.23
Q3 25
$1.10
$1.98
Q2 25
$1.06
$1.42
Q1 25
$0.50
$-0.77
Q4 24
$-4.17
$0.99
Q3 24
$1.33
$1.57
Q2 24
$1.74
$0.76
Q1 24
$1.30
$-0.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRL
CRL
GVA
GVA
Cash + ST InvestmentsLiquidity on hand
$213.8M
$600.2M
Total DebtLower is stronger
$2.1B
$1.3B
Stockholders' EquityBook value
$3.2B
$1.2B
Total Assets
$7.1B
$4.0B
Debt / EquityLower = less leverage
0.68×
1.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRL
CRL
GVA
GVA
Q4 25
$213.8M
$600.2M
Q3 25
$207.1M
$547.2M
Q2 25
$182.8M
$385.3M
Q1 25
$229.4M
$422.8M
Q4 24
$194.6M
$585.6M
Q3 24
$210.2M
$472.4M
Q2 24
$179.2M
$377.2M
Q1 24
$327.0M
$337.3M
Total Debt
CRL
CRL
GVA
GVA
Q4 25
$2.1B
$1.3B
Q3 25
$2.2B
$1.3B
Q2 25
$2.3B
$740.4M
Q1 25
$2.5B
$739.7M
Q4 24
$2.2B
$739.0M
Q3 24
$2.3B
$738.6M
Q2 24
$2.4B
$738.9M
Q1 24
$2.7B
$553.2M
Stockholders' Equity
CRL
CRL
GVA
GVA
Q4 25
$3.2B
$1.2B
Q3 25
$3.4B
$1.2B
Q2 25
$3.4B
$1.1B
Q1 25
$3.2B
$993.5M
Q4 24
$3.5B
$1.0B
Q3 24
$3.8B
$1.0B
Q2 24
$3.7B
$931.7M
Q1 24
$3.6B
$946.5M
Total Assets
CRL
CRL
GVA
GVA
Q4 25
$7.1B
$4.0B
Q3 25
$7.5B
$4.1B
Q2 25
$7.6B
$3.1B
Q1 25
$7.6B
$2.9B
Q4 24
$7.5B
$3.0B
Q3 24
$8.0B
$3.1B
Q2 24
$7.9B
$2.9B
Q1 24
$8.2B
$2.6B
Debt / Equity
CRL
CRL
GVA
GVA
Q4 25
0.68×
1.14×
Q3 25
0.64×
1.16×
Q2 25
0.70×
0.70×
Q1 25
0.79×
0.74×
Q4 24
0.65×
0.73×
Q3 24
0.62×
0.73×
Q2 24
0.65×
0.79×
Q1 24
0.73×
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRL
CRL
GVA
GVA
Operating Cash FlowLast quarter
$147.5M
$179.3M
Free Cash FlowOCF − Capex
$58.6M
$128.8M
FCF MarginFCF / Revenue
5.9%
11.0%
Capex IntensityCapex / Revenue
8.9%
4.3%
Cash ConversionOCF / Net Profit
3.45×
TTM Free Cash FlowTrailing 4 quarters
$518.5M
$330.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRL
CRL
GVA
GVA
Q4 25
$147.5M
$179.3M
Q3 25
$213.8M
$284.2M
Q2 25
$204.6M
$1.8M
Q1 25
$171.7M
$3.6M
Q4 24
$159.4M
$172.8M
Q3 24
$251.8M
$261.5M
Q2 24
$193.5M
$-2.0M
Q1 24
$129.9M
$24.1M
Free Cash Flow
CRL
CRL
GVA
GVA
Q4 25
$58.6M
$128.8M
Q3 25
$178.2M
$257.5M
Q2 25
$169.3M
$-27.0M
Q1 25
$112.4M
$-28.6M
Q4 24
$83.7M
$144.6M
Q3 24
$213.1M
$220.2M
Q2 24
$154.0M
$-41.0M
Q1 24
$50.7M
$-3.8M
FCF Margin
CRL
CRL
GVA
GVA
Q4 25
5.9%
11.0%
Q3 25
17.7%
18.0%
Q2 25
16.4%
-2.4%
Q1 25
11.4%
-4.1%
Q4 24
8.4%
14.8%
Q3 24
21.1%
17.3%
Q2 24
15.0%
-3.8%
Q1 24
5.0%
-0.6%
Capex Intensity
CRL
CRL
GVA
GVA
Q4 25
8.9%
4.3%
Q3 25
3.5%
1.9%
Q2 25
3.4%
2.6%
Q1 25
6.0%
4.6%
Q4 24
7.5%
2.9%
Q3 24
3.8%
3.2%
Q2 24
3.8%
3.6%
Q1 24
7.8%
4.1%
Cash Conversion
CRL
CRL
GVA
GVA
Q4 25
3.45×
Q3 25
3.93×
2.76×
Q2 25
3.91×
0.02×
Q1 25
6.74×
Q4 24
4.17×
Q3 24
3.61×
3.31×
Q2 24
2.06×
-0.05×
Q1 24
1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRL
CRL

Discovery And Safety Assessment Segment$591.6M60%
Manufacturing Support Segment$196.4M20%
Transferred At Point In Time$108.0M11%
Transferred Over Time$98.3M10%

GVA
GVA

Public$680.2M58%
Private$260.1M22%
Asphalt$116.9M10%
Aggregates$107.9M9%
Collaborative Arrangement$7.0M1%
Performance Obligations$3.5M0%

Related Comparisons